Matteo Bellone Selected Research

Matteo Bellone Research Topics

Disease

52	Neoplasms (Cancer) 01/2022 - 02/2002
19	Prostatic Neoplasms (Prostate Cancer) 10/2021 - 07/2008
11	Adenocarcinoma 11/2019 - 01/2005
5	Disease Progression 01/2019 - 03/2011
5	Melanoma (Melanoma, Malignant) 01/2018 - 06/2004
3	Inflammation (Inflammations) 01/2020 - 03/2011
3	Experimental Melanoma 01/2018 - 07/2003
3	Hematologic Neoplasms (Hematological Malignancy) 08/2013 - 05/2010
3	Lymphoma (Lymphomas) 01/2009 - 02/2002
2	Monoclonal Gammopathy of Undetermined Significance 01/2022 - 01/2019
2	Multiple Myeloma 01/2022 - 01/2016
2	Neoplasm Metastasis (Metastasis) 01/2020 - 07/2008
1	Starvation 12/2020
1	Fibrosarcoma 11/2019
1	Phyllodes Tumor (Cystosarcoma Phylloides) 01/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017
1	Merkel Cell Carcinoma 01/2017
1	Hodgkin Disease (Hodgkin's Disease) 01/2017
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2017
1	Chills 11/2014
1	Erythema 11/2014
1	Hypoxia (Hypoxemia) 09/2014

Drug/Important Bio-Agent (IBA)

11	AntigensIBA 01/2017 - 02/2002
11	VaccinesIBA 11/2014 - 07/2003
8	Peptides (Polypeptides)IBA 11/2019 - 10/2004
5	AndrogensIBA 10/2021 - 07/2008
5	CytokinesIBA 01/2020 - 12/2008
4	Immune Checkpoint InhibitorsIBA 01/2018 - 01/2017
4	Monoclonal AntibodiesIBA 01/2018 - 01/2013
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2014 - 10/2004
4	Pharmaceutical PreparationsIBA 03/2012 - 05/2008
4	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2008 - 02/2002
3	Proteins (Proteins, Gene)FDA Link 12/2020 - 05/2005
3	LigandsIBA 01/2019 - 05/2013
3	Minor Histocompatibility AntigensIBA 01/2017 - 05/2010
3	ChemokinesIBA 08/2013 - 03/2012
2	Hormones (Hormone)IBA 10/2021 - 08/2009
2	Biomarkers (Surrogate Marker)IBA 05/2021 - 01/2019
2	Interleukin-17 (Interleukin 17)IBA 01/2020 - 12/2018
2	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2019 - 12/2008
2	InterleukinsIBA 01/2019 - 01/2018
2	InterferonsIBA 01/2018 - 10/2013
2	Therapeutic UsesIBA 01/2018 - 01/2017
2	H antigenIBA 01/2017 - 02/2011
2	Neoplasm Antigens (Tumor Antigens)IBA 07/2014 - 01/2005
2	Sildenafil Citrate (Viagra)FDA Link 03/2011 - 01/2009
2	Arginine (L-Arginine)FDA Link 03/2011 - 01/2009
2	NG-Nitroarginine Methyl Ester (L-NAME)IBA 03/2011 - 01/2009
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	Bortezomib (Velcade)FDA Link 01/2021
1	Liposomes (Liposome)IBA 01/2021
1	ChromatinIBA 01/2021
1	Androgen Antagonists (Antiandrogens)IBA 12/2020
1	bicalutamide (Casodex)FDA LinkGeneric 12/2020
1	IronIBA 12/2020
1	Immunomodulating AgentsIBA 01/2020
1	lactosamineIBA 01/2020
1	Carrier Proteins (Binding Protein)IBA 01/2020
1	Polysaccharides (Glycans)IBA 01/2020
1	Galectin 3 (LGALS3)IBA 01/2020
1	Interleukin-12 (IL 12)IBA 11/2019
1	GoldIBA 11/2019
1	PerforinIBA 01/2019
1	T-Cell Intracellular Antigen-1IBA 01/2019
1	Interleukin-5 (Interleukin 5)IBA 12/2018
1	Blocking AntibodiesIBA 12/2018
1	MucinsIBA 01/2018
1	Immunoglobulins (Immunoglobulin)IBA 01/2018
1	AntibodiesIBA 01/2018
1	Granzymes (Granzyme)IBA 01/2018
1	Immune Checkpoint ProteinsIBA 01/2018
1	Imatinib Mesylate (Gleevec)FDA Link 01/2017
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2017
1	Chromogranin AIBA 01/2016
1	Fibrinolysin FDA Link 01/2016
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2016
1	TenascinIBA 05/2015
1	HLA-A*02:01 antigenIBA 11/2014
1	human CNGRC fusion protein tumor necrosis factor-alphaIBA 11/2014
1	HLA-A Antigens (HLA-A)IBA 11/2014
1	Antineoplastic Agents (Antineoplastics)IBA 09/2014
1	Natural Killer Cell ReceptorsIBA 05/2013
1	BuffersIBA 01/2013
1	Proton Pump InhibitorsIBA 01/2013
1	vitamin D-binding protein-macrophage activating factorIBA 12/2012
1	NGR peptideIBA 03/2012

Therapy/Procedure

13	Therapeutics 01/2022 - 06/2004
13	Immunotherapy 01/2022 - 03/2004
4	Biological Therapy 01/2022 - 01/2017
3	Hematopoietic Stem Cell Transplantation 01/2022 - 05/2010
3	Drug Therapy (Chemotherapy) 01/2022 - 03/2005
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2018 - 01/2017
2	Transplantation 08/2013 - 02/2011
2	Cell Transplantation 08/2013 - 05/2010
1	Castration 10/2021
1	Fecal Microbiota Transplantation 10/2021
1	Investigational Therapies (Experimental Therapy) 01/2021
1	Prostatectomy (Retropubic Prostatectomy) 01/2019
1	Aftercare (After-Treatment) 11/2014